Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Return on Equity: 2014-2018

Historic Return on Equity for Armata Pharmaceuticals (ARMP) over the last 4 years, with Sep 2018 value amounting to -1.53%.

  • Armata Pharmaceuticals' Return on Equity rose 25.00% to -1.53% in Q3 2018 from the same period last year, while for Sep 2018 it was -1.53%, marking a year-over-year increase of 25.00%. This contributed to the annual value of -1.47% for FY2017, which is 21.00% up from last year.
  • Armata Pharmaceuticals' Return on Equity amounted to -1.53% in Q3 2018, which was down 1,902.39% from -0.08% recorded in Q2 2018.
  • Armata Pharmaceuticals' Return on Equity's 5-year high stood at 3.37% during Q3 2014, with a 5-year trough of -79.08% in Q1 2015.
  • For the 3-year period, Armata Pharmaceuticals' Return on Equity averaged around -1.32%, with its median value being -1.29% (2016).
  • As far as peak fluctuations go, Armata Pharmaceuticals' Return on Equity crashed by 7,987bps in 2015, and later soared by 7,794bps in 2016.
  • Armata Pharmaceuticals' Return on Equity (Quarterly) stood at -5.86% in 2014, then soared by 513bps to -0.74% in 2015, then slumped by 70bps to -1.44% in 2016, then skyrocketed by 32bps to -1.11% in 2017, then climbed by 25bps to -1.53% in 2018.
  • Its last three reported values are -1.53% in Q3 2018, -0.08% for Q2 2018, and -1.11% during Q4 2017.